STatin TReatment for COVID-19 to Optimise NeuroloGical recovERy (STRONGER): study protocol for a randomised, open label clinical trial in patients with persistent neurological symptoms after COVID-19 infection
Introduction Increasing awareness of the high frequency, wide spectrum and disabling nature of symptoms that can persist following COVID-19 infection has prompted the investigation of management strategies. Our study aims to determine the effectiveness of atorvastatin on cognitive function, physical...
Saved in:
| Main Authors: | Sharon L Naismith, Mark Woodward, Ruth Peters, Xia Wang, Craig S Anderson, Sophia Zoungas, Cheryl Carcel, Paula Muñoz-Venturelli, Karin Leder, Ian H Harding, Meng Law, Julian Elliott, Owen Hutchings, Carlos Delfino, Xiaolei Lin, Nirupama Wijesuriya, Ximena Stecher |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-04-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/15/4/e089382.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COVID-19 and neurological problems
by: Pushpendra Nath Renjen, et al.
Published: (2021-01-01) -
Visual and neurological complications of COVID-19
by: E. E. Ioileva, et al.
Published: (2023-07-01) -
COVID-19 infection: neurological symptoms and encephalitis
by: A. Jasionis, et al.
Published: (2020-06-01) -
From COVID-19 to long COVID; the forms of the neurological manifestations
by: Sana Ahuja, et al.
Published: (2023-10-01) -
Neurological aspects of COVID-19. Management of patients with neurological diseases considering epidemiological situation
by: E. G. Demianovskaia, et al.
Published: (2021-06-01)